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Summary 
Src homology 3 (SH3) domains have been suggested to play an important role in the assembly 
of the superoxide-forming  nicotinamide adenine dinudeotide phosphate (NADPH) oxidase upon 
activation of phagocytes, which involves  the  association  of membrane-bound and cytosolic 
components. We studied the translocation of the cytosolic proteins to the plasma membrane 
in neutrophils of a patient with a point mutation in the gene encoding the light chain ofcytochrome 
bsss. This mutation leads to a substitution at residue  156 of a proline into a glutamine in a 
putative SH3 binding domain of p22-phox  (Dinauer, M.,  E.  A. Pierce,  K.  W.  Erickson, T. 
Muhlebach, H. Messner, K. A. Seger, S. H. Orkin, and J. T. Curnutte. 1991. Proc. Natl. Acad. 
Sci. 88:11231). In PMA-stimulated neutrophils and in a eell-free translocation assay with neutrophfl 
membranes and cytosol,  association  of the cytosolic proteins p47-phox and p67-phox with the 
membrane fraction of the patient's neutrophils was virtually absent. In contrast, when solubilized 
membranes of the patient's neutrophils were activated with phospholipids in the absence ofcytosol 
(Koshkin, V., and E. Pick. 1993. FEBS[Fed. Eur. Biochem. Soa]Lett. 327:57), the rate of NADPH- 
dependent oxygen uptake was observed at a rate similar to that of control membranes. We suggest 
that the binding of an SH3 domain of p47-phox to p22-phox, and thus activation of the oxidase, 
does not occur in the neutrophils of this patient, although under artificial conditions, electron 
flow from NADPH to oxygen in cytochrome bsss is possible. 
N 
'eutrophils and other phagocytic cells contain a multi- 
component electron transfer chain known as the nico- 
tinamide adenine dinucleotide phosphate (NADPH) 1 oxidase 
(1). This enzyme is responsible for production of microbi- 
cidal oxidants upon activation of phagocytes. For an active 
NADPH oxidase at least five different proteins are required: 
two  subunits  of the  membrane-bound cytochrome bsss, 
gp91-phox and p22-phox,  and three cytosolic proteins, p47- 
phox,  p67-?hox,  and a low molecular weight GTP-binding 
protein, either rac-1 (in macrophages) or rac-2 (in neutrophils) 
(2, 3). Recently, a fourth cytosolic oxidase component was 
found: p40-phox,  which is probably involved in stabilizing 
1 Abbreviations  used in  this paper:  CGD,  chronic granulomatous disease; 
GTP-q/-S, guanosine 5'-3-O-(thio)triphosphate;  NADPH, nicotinamide 
adenine dinucleotide phosphate; SH3, src homology. 
p67-phox (4, 5). Upon cell activation, p47-phox and p67-phox 
translocate  to  the plasma membrane, to  form  the active 
membrane-bound NADPH oxidase (6-8). Both p47-phox and 
p67-phox contain two so-called src homology (SH3) domains 
(9, 10), which are known to be involved in protein-protein 
interactions (11, 12). In addition, both proteins as well as 
p22-phox possess proline-rich regions that are putative SH3 
counter structures (13, 14). 
Recently, it has been described  that superoxide produc- 
tion can be elicited in solubilized cytochrome bsss by a mix- 
ture of phospholipids in the absence of cytosolic proteins (15, 
16). This suggests that cytochrome bsss contains the com- 
plete electron transport chain from NADPH to superoxide, 
and that the cytosolic components merely function as acti- 
vators. 
NADPH oxidase activity is absent in patients with chronic 
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tients suffer from recurrent severe bacterial and fungal infec- 
tions. There are four genetic causes of CGD, reflecting defects 
in four different components of the NADPH oxidase  (for 
reviews see references 1,  17,  18). When the gene encoding 
p22-phox or gp91-ph~ is affected, both subunits ofcytochrome 
bsss are typically absent (19-22). 
We studied the only CGD patient described thus far with 
a missense mutation in the cytoplasmic part (23) of p22-phox 
with normal amounts of cytochrome bsss (24). This patient 
has a missense mutation in codon 156 (numbered according 
to 25),  predicting an amino acid substitution of a proline 
into a glutamine residue.  This substitution is located in a 
proline-rich region of p22-phox that could be involved in the 
binding of an SH3 domain of p47-phox or p67-phox. Here, 
we report that for this patient both in PMA-activated neu- 
trophils and in the cell-free assay, hardly any translocation 
of cytosolic proteins was observed.  In addition, when solu- 
bilized neutrophil membranes of the patient were stimulated 
with phospholipids in the absence of cytosol, oxidase activity 
was observed comparable with that of neutrophil membranes 
from heahhy donors. 
Materials and Methods 
Materials.  Guanosine  5'-3-O-(thio)triphosphate (GTP-'y-S) and 
NADPH were purchased from Boehringer (Mannheim, Germany). 
Reagents and molecular weight markers for SDS-PAGE were from 
Bio-Rad  Laboratories  (Richmond, CA). Nitrocellulose  sheets BA84 
for Western blotting were obtained from Schhicher & Schuell 
(Dassd, Germany). Antibodies used in this study were mAb 449 
and 48, directed against p22-phox and gp91-phox, respectively  (22). 
Rabbit antisera  specific  for either p47-phox  or p67-phox, were raised 
against synthetic peptides identical to the hst 12 residues of the 
COOH-termini. Goat antibody against rabbit Ig conjugated to 
horseradish  peroxidase  was produced within our institute (Central 
Laboratory of the Netherlands, Red Cross Blood Transfusion  Ser- 
vice). The enhanced  chemiluminescence  kit with luminol was from 
Amershan International  (ECL; Amersham,  Buckinghamshire,  UK). 
X-Omat AK diagnostic films were from Kodak Co. (Rochester, 
NY). A synthetic peptide resembling region 149-162 of p22-phox 
and a peptide resembling the same  region, but containing the same 
Pro --* Gln substitution as the patient were purchased from Eu- 
rosequence (Groningen, The Netherlands), and dissolved in dis- 
tilled water to a concentration of 10 mM. The lipids were obtained 
from Sigma Chemical Co. (St. Louis, MO) (product numbers ap- 
pear within parentheses): t-ct-phosphatidylcholme type II-S from 
soybean, 14% (P5638) and L-ot-phosphatidic  acid, sodium salt, from 
egg yolk lecithin, 98% (P9511). 
Isolation andFroctionation  of  Leu/agytes.  Human neutrophils  were 
prepared on one occasion from 100 ml of citrated blood from the 
CGD patient after obtaining informed consent. Neutrophils from 
a healthy donor were isolated in parallel. Neutrophils were isolated 
and fractionated by sonication as described (26, 27). 
Translocation of Cytosolic Proteins in Intact Neutrophils.  40  x  106 
cells of the patient and of a healthy donor were incubated with 
PMA (100 ng/ml) or without PMA for 10 min at 37~  The cells 
were then resuspended and sonicated in 1 ml of ice-cold oxidase 
buffer (containing 75 mM NaC1, 10 mM Hepes, 170 mM sucrose, 
1 mM MgC12, 0.5 mM EGTA, 10 #M ATP, and 2 mM azide, pH 
7.0) with 5/zM GTP-7-S and 100 #g/ml PMSE After centrifuga- 
tion (10 min, 800g), the sonicate  was layered  on a sucrose gradient 
as described before (26), with 1 mM MgCh, 40 mM NaC1, 0.5 
mM EGTA, and 5/zM GTP-~/-S added to the 15% sucrose layer. 
After centrifugation (45 rain, 100,000 g), 500 #l of plasma mem- 
branes was harvested. For immunodetection, 25 #l of membrane 
fraction was dissolved  in SDS sample buffer (125 mM Tris, pH 6.8, 
20% [wt/vol] SDS, 10% [vol/vol] E-ME), and was loaded on a 
10% polyacrylamide  gel according to Laemmli (28), in a gel ap- 
paratus (Mini-Protean II; Bio-Rad Laboratories). Western blotting 
was performed in a Mini Tram-Blot (Bio-Rad) cell according to 
the manufacturers  recommendations.  Detection of  proteins was per- 
formed as described previously (29). When the blot was stained 
for two sets of proteins, the nitrocellulose  was stripped with 62.5 
mM Tds, pH 6.7, 2% SDS, and 100 mM/3-ME after the first 
staining. 
Su~roxide Assay.  NADPH oxidase activity with neutrophil 
membranes and cytosol was measured as the superoxide dismutase 
(SOD)-sensitive reduction ofcytochrome c in a spectrophotometer 
(model Lambda 2; Perkin Elmer Corp., Norwalk, CT). The con- 
tents of six cuvettes measured in parallel were stirred continuously 
and were thermostatted at 28~  Plasma  membranes  (10/~g of  pro- 
tein) and cytosol (200 #g of protein) were incubated in 0.8 ml of 
oxidase buffer and 60 #M cytochrome c. After 2 rain of incuba- 
tion, oxidase assembly  was induced by addition of SDS (100 #M) 
and GTP-~,-S (10/~M). After 5 min, NADPH (250/~M) was added 
and the rate of cytochrome c reduction was measured at 550 nm. 
Translocation of Cytosolic Proteins in the Cell-free System.  Neu- 
trophil plasma membranes (20/zg protein) were mixed with neu- 
trophil cytosol (400 ~g protein) in I ml of oxidase buffer. Subse- 
quently, SDS (100 #M) and GTP-'y-S (10 #M) were added. After 
10 rain at room temperature, the mixture was loaded on a discon- 
tinuous sucrose gradient as described (30). NADPH oxidase ac- 
tivity of one-fifth part of the reisolated membranes was measured 
without cytosol in the presence of SDS (100/zM) and GTP-~/-S 
(10 #M). After 2 min, NADPH (250 #M) was added and the rate 
of cytochrome c reduction was measured at 550 nm. In addition, 
the supernatant (50/zl) and four-fifths part of the reisolated mem- 
branes were analyzed  by immunoblot for the presence of p47-phox, 
p67-phox, and cytochrome bsss subunits. 
Oxygen Consumption in Plasma Membranes without Cytosol Ac. 
cording to Koshkin and Pick (15).  6 #g of membrane protein (in 
30 #1) was solubilized  with 10 #1 of  buffer A (50 mM Na-phosphate, 
pH 7.4, 1 mM EGTA, 1 mM MgC12, 2 mM NAN3, 1 mM dithio- 
treitol, and 20% glycerol) with 80 mM 1-O-Octyl-3-n-glucopy- 
ranoside. Subsequently, the membranes were reconstituted with 
4 #g of t-ct-phosphatidylcholine  and t-c~-phosphatidic  acid, diluted 
eightfold in assay  buffer (65 mM K,Na-phosphate buffer, pH 7.0, 
1 mM MgC12, 1 mM EGTA, 2 mM NAN3, 1 #M flavin adenine 
dinudeotide [FAD], and 30 #M SDS) and allowed to stand on ice 
for 30 rain. Oxygen consumption was measured with an oxygen 
electrode after addition of 250 #M NADPH. 
Results 
~anslocation of  p47-phox and p67-phox in N~trophil~ of the 
CGD Patient.  We studied the only CGD patient described 
thus far with a missense mutation in the cytoplasmic tail of 
p22-phox  leading  to  normal  amounts  of  nonfunctional 
cytochrome bsss (24).  This  patient  has  a  mutation  that 
predicts a Pro ~  Gin substitution at residue 156 of p22=phox. 
To investigate the functional effect of this substitution, we 
studied the association of the cytosolic proteins with the plasma 
membranes of PMA-activated neutrophils. For this purpose, 
neutrophils of the patient and those of a healthy donor were 
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branes  of activated  neutrophils.  40  x  106 cells 
were incubated with or without 100 ng of PMA 
per ml for 7 min at 37~  as indicated.  Fraction- 
ation of the cells was performed  as described in 
Materials and Methods. Plasma membrane proteins 
of 2  x  106 cells were separated by 10% PAGE  and 
blotted  onto  nitrocellulose.  (A)  The  blot  was 
stained for both subunits of cytochrome bsss with 
mAbs 48 (against gp91-phox) and 449 (against p22- 
phox). (13) The same blot stained with rabbit  an- 
tisera against p47-phox and p67-phox. The samples 
were obtained  from the A22 + CGD patient  or 
control donor as indicated. 
incubated with or without PMA, and subcellular fractions 
were isolated. Fig. 1 shows the Western blot of the plasma 
membranes of these neutrophils,  stained for cytochrome bsss 
or p47-phox and p67-phox.  The intensity of the bands  of 
cytochrome bsss in this plasma membrane fraction was in- 
creased when the cells were treated with PMA,  because 
cytochrome bsss is recruited from the specific granules to the 
plasma membrane upon cell activation (Fig. 1 A). Fig. 1 B 
clearly shows a strongly reduced translocation of both cyto- 
solic oxidase components to the neutrophil membranes  of 
the patient upon stimulation with PMA. 
Effect  of Point Mutation  lS6Pro -'-* Gin  in  p22-phox  on 
NADPH Oxidase  Assembly.  We also studied the neutrophil 
membranes of the CGD patient for their ability to bind p47- 
phox and p67-phox in a cell-free translocation  assay. Reiso- 
lated control membranes preincubated with control cytosol 
produced 788  __  24 (mean  _+  SEM, n  =  3)nmol of su- 
peroxide/min  x  mg membrane  protein, whereas the patient's 
neutrophil membrane fraction  preincubated  with control 
cytosol produced only 2  _  I nmoles of superoxide/min x 
mg membrane protein. 
The supernatant of the sucrose gradient and the reisolated 
membranes were also analyzed on an immunoblot to deter- 
mine the translocation of  cytosolic oxidase components. Fig. 
2 A  shows a decreased amount of cytosolic proteins in the 
supernatant of  only the control experiment. Fig. 2 B demon- 
strates the presence of  equal amounts of  the membrane-bound 
oxidase components gp91-phox and p22-phox in the reiso- 
lated membrane fraction of  the control and the patient. When 
the same blot was treated with antibodies directed against 
the cytosolic  oxidase components p67-phax and p47-phox (Fig. 
2 B), the control membranes  showed a significant associa- 
tion with p47-phox and p67-phox. In contrast,  the neutro- 
phil membranes  of the patient did not contain detectable 
amounts of cytosolic oxidase proteins. Also, when the incu- 
bation mixture of  control plasma membranes and cytosol was 
Figure  2.  Western  blot analysis of 
neutrophil membranes reisolated from 
the cell-free activation  system. Plasma 
membranes  were mixed with cytosol 
and activated with SDS and GTP3'S in 
the  first  two  lanes  as  described  in 
Materials and Methods. After centrifu- 
gation through a 15% (wt/vol) sucrose 
layer, the supernatant  and  membrane 
fractions  were harvested.  80%  of the 
membrane  fraction  was  precipitated 
with  10%  (wt/vol) TCA and  redis- 
solved in SDS sample buffer. After 10% 
PAGE, both supernatant and membrane 
proteins  were blotted onto nitrocellu- 
lose. The supernatant  (A) was stained 
with a mixture of two rabbit  antisera 
directed against  p47-phox and p67-phox. The membrane  fraction  (/3) was stained with a mixture of mAbs 449 and 48 (/eft), or with rabbit  antisera 
against p47-phox and p67-phox (right). The source of plasma membranes  in the first two lanes is indicated;  (con) control donor,  (pat) A22 § CGD pa- 
tient. In lanes 3 (not activated [N.A.]), SDS and GTP-3,-S were omitted from the incubation  mixture with control membranes.  The results  shown 
are representative  of three  independent  experiments. 
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branes contained no detectable amounts ofp47-phox and p67- 
phox (lane N.A.). 
To consolidate the importance of the putative SH3 binding 
domain 149-162 ofp22-phox in the assembly of the NADPH 
oxidase, we explored the effect of a synthetic peptide resem- 
bling this region in the cell-free assay. Other peptides have 
recently been shown to affect this process efficiently with an 
ICs0 (concentration giving 50%  inhibition) lower than 30 
/~M (29, 31). However, this peptide did not show a potent 
inhibitory  effect:  the  ICs0 amounted  to  about  100  /zM 
(results not shown). Furthermore, a peptide containing the 
same substitution as the patient, inhibited the cell-free assay 
to the same extent. 
Oxygen Consumption  in Neutrophil  Plasma Membranes  without 
Cytosol.  If, indeed, residue 156 of p22-phox is required for 
the interaction with p47-phox, it is conceivable that electron 
flow in cytochrome bs5s might still be possible,  despite the 
mutation of 1022-phox. Recently, it has been described that 
relipidation of solubilized cytochrome bsss can elicit NADPH- 
dependent superoxide (02-)  production in the absence  of 
cytosolic oxidase proteins (15), suggesting that cytochrome 
bsss contains the complete electron-trans10orting  apparatus  of 
the NADPH  oxidase,  and that  the cytosolic components 
merely function as activators (15). Therefore, we tested the 
neutrophil membranes of the patient for oxygen consump- 
tion in the absence of cytosol. For this purpose, membranes 
obtained from control donors or CGD patients were solubi- 
lized and activated with phospholipids in the presence of FAD 
and NADPH according to previous protocols (15). The results 
are shown in Table 1. The neutro10hil membranes of the control 
donors exhibited a significant oxygen consumption, whereas 
the neutro10hil membranes of two cytochrome bsss-deficient 
CGD patients showed a very low oxygen consumption, thus 
confirming a cytochrome bsss-dependent mechanism. Plasma 
membranes from the patient described in this study, with 
Table  1.  Oxygen Consumption of Solubilized Membranes 
Activated with Phospholipids 
Source of  O2/min  x  mg 
plasma  membranes  membrane  protein 
nmol 
Controls  189  _+  5* 
X91  ~ patient  1  62 
X91 ~ patient 2  19 
A22 § patient  220  +_  12" 
Patients'  or control neutrophil membranes  (6/~g) were solubilized with 
octylglucoside and incubated with phosphatidylcholine/phosphatidic  acid 
on ice for 30 min. Oxygen consumption was measured in 500 ~1 after 
addition of 250/xM of NADPH. Values were corrected for oxygen con- 
sumption  in  the  absence of  membranes,  which  was  54  _+  7  nmol 
O2/min. X91  ~ are X-linked CGD patients,  affected in gp91-phox,  lack- 
ing cytochrome bsss; A22+  is the patient  discussed in this report, with 
the autosomally  inherited defect in p22-phox. 
* Mean  +  SEM of three  separate experiments. 
a 156pr0 ~  Gin substitution in p22-phox, showed a similar 
rate of oxygen consumption as control membranes, indicating 
an intact electron flow in the mutated cytochrome bs58 of 
this patient under these experimental conditions. 
Discussion 
It is well established that so-called SH3 domains are involved 
in protein-protein interactions (11, 12). Recently, the counter 
structure for these SH3 domains has been identified as 10roline  - 
rich stretches found in various proteins (14). P47-phox and 
p67-phox of the NADPH oxidase each contain two SH3 do- 
mains  and  one  putative  SH3  binding  domain.  In  the 
membrane-bound cytochrome bsss only p22-phox contains 
such a putative SH3-binding  domain, comprising residue 
149-162.  Possibly, residues 176-195  represent another SH3- 
binding domain. In this report we studied the importance 
of the proline-rich region of 149-162  in p22-phox in the as- 
sociation of the cytosolic oxidase components with cytochrome 
b55s, by the use of neutrophils from a CGD patient with a 
lS6pro -~ Gin substitution  of p22-phox (24). 
Upon PMA stimulation, the translocation of both p47- 
phox and 1067-phox was hardly detectable with the neutro- 
phils derived from the patient, whereas translocation could 
clearly be demonstrated in neutro10hils from control donors 
(Fig.  1). Also in an in vitro translocation assay, the mem- 
brane fraction of the patient failed to support association of 
these cytosolic oxidase components (Fig.  2).  These results 
indicate an important contribution of residue 156 of p22- 
phox to the binding of one or more cytosolic components. 
Most likely, binding of p47-phox is disturbed, because 1047  . 
phox is thought to interact first with cytochrome bsss (32, 
33).  As a consequence, p67-phox binding is also absent, be- 
cause translocation of this latter protein is dependent on the 
presence of 1047-phox (8). 
To assess the consequence of the 156pro --- Gin in p22- 
phox for electron transfer within the cytochrome, solubilized 
membranes of control neutrophils and patient  neutrophils 
were incubated with phospholi10ids. Both showed a significant 
oxygen consumption upon addition of NADPH (Table 1), 
indicating that the mutated cytochrome bsss in this patient 
is capable of a normal electron transport. This oxygen con- 
sumption  is  indeed  cytochrome  bsss dependent,  as  was 
proven by the very low activity in neutrophil membranes from 
cytochrome bsss-deficient CGD patients. Therefore, the dys- 
function of the NADPH oxidase in the neutro10hils from the 
A22 + CGD patient is caused by a defective activation mech- 
anism rather than by a defective cytochrome bsss. 
Recently, we have described another CGD patient with 
a defective translocation of p47-phox and p67-phox (29). This 
patient  was  characterized  as  an  X-linked  CGD  patient 
(X91 +) with a ~Asp --~ Gly mutation in g1091-phox  with 
normal amounts of nonfunctional cytochrome bsss. Reli10i- 
dated neutro10hil membranes of this patient showed a strongly 
reduced oxygen consumption, comparable with that of mem- 
branes of cytochrome bsss-deficient  CGD  patients  (results 
not shown). 
The mutations found in these two CGD cytochrome bsss- 
2332  Point  Mutation in p22-phox  Leading to Defective Translocation positive patients indicate at least two binding sites for p47- 
phox in cytochrome bsss. First, a region around residue 500 
of gp91-phox, with which p47-phox interacts possibly through 
electrostatic forces. Second, the proline-rich region 149-162 
of p22-phox to which p47-phox binds via its SH3 domains. 
Possibly, the first interaction enables the second interaction 
to occur, explaining the different effects of peptides resem- 
bling  these  domains.  Evidently,  the  exact  mechanism  of 
binding of p47-phox to cytochrome bsss induced by neutro- 
phil activation remains to be elucidated. 
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